| A first strategic approach: Cuban and Scottish Biotech sectors are looking for mutual benefits |
| Havana - May, 29. Ten Cuban
scientists and business development executives participated in an inward
mission to Scotland organized by the Glasgow City Councils and the United
Kingdom Embassy in Havana. This mission is a first approach between Cuban
and Scottish biotechnology companies and institutions for a mutual recognition
before starting to identify actual interests on joint development of research
projects for human health and agriculture. The Cuban institutions participating
in the first meeting were: Centre for Molecular Immunology, Centre for
Genetic Engineering and Biotechnology, Finlay Institute, Neuroscience
Centre, Blood Derivatives Plant and National Institute of Oncology and
Radiobiology.
An overview presentation on Cuban Biotechnology as well as separate presentations on major activities at each Cuban institution was performed in the Glasgow City Chamber. Twenty Scottish companies and institutions were invited to these presentations to identify potential partnership opportunities. The Scottish research institutions participating in this historical meeting were: Roslyn Institute, Edinburgh University and Scottish Health Innovations. Additional meetings took place at the Lord Provost's Office, Glasgow University and Strathclyde Institute for Drug Research, among other centres. Cuban Biotechnology has closed
the value chain from research to commercialisation, generating positive
cash flow and growth rate, more than 10 years ago. At the same time
Scottish companies have the formula to survive biotech slump in Europe.
Cuban representatives drew a tangible conclusion, during the mission:
Cuba and Scotland can benefit from alliances in a transparency environment. |